SEMA3A and neoplasm: For example, by antagonizing the interaction between NRP1 and Sema3A, Pan and colleagues, demonstrated an inhibition of tumor angiogenesis and tumor growth in vivo, effects that were compounded when combined with antibodies directed against VEGF binding (24).